Skip to content

US · PIII · MEDICAL - CARE FACILITIES

P3 Health Partners Inc. (PIII) intrinsic value and stock valuation

$1.69as of 2026-11-21 · Mkt cap 33.32M

Data updated · price as of 2026-11-21

Strongly undervaluedIC value is more than 50% above the price. The exact IC value, upside and the fair-value band are available with Pro.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

P3 Health Partners Inc. DCF and intrinsic value

InvestorsCraft values PIII with the Chepakovich two-stage DCF model — currently rated strongly undervalued. How the model works · Run your own DCF prefilled from PIII’s statements →

P3 Health Partners Inc. Graham Number

The Graham Number is not defined for negative earnings or book value. Guide · Calculator →

Healthcare · Medical - Care Facilities Henderson, NV 89074 p3hp.org

How the business is doing

Fiscal 2018–2025, USD

Revenue
$1.46B+24.3% 5y CAGRd
20182025
Net income
-$-147.95M
20182025
Free cash flow
-$-91.16M
20182025
Total equity
-$-140.24M
20192025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2018–2025, USD
20252024202320222021
Revenue$1.46B$1.5B$1.27B$1.05B$637.4M
Operating income-$-270.3M-$-320.66M-$-167.93M-$-1.56B-$-187.95M
Net income-$-147.95M-$-135.85M-$-57.77M-$-270.13M-$-156.48M
EPSd-$-45.24M-$-46.21M-$-30.41M-$-325.46M-$-188.53M
Operating cash flow-$-91.24M-$-110.13M-$-76.03M-$-126.02M-$-66.47M
Capital expenditure$80K$0.00-$-1.83M-$-2.23M-$-3.41M
Free cash flow-$-91.16M-$-110.13M-$-77.86M-$-128.25M-$-69.88M
Total assets$656.6M$783.4M$861M$876.7M$2.36B
Total debt$284.9M$166.2M$124.6M$107.5M$92M
Net debt$259.9M$127.4M$88.3M$89.1M-$-48.46M
Total equity-$-140.24M$149.5M$433.7M$522.7M$2.06B
Cash and short-term investments$25M$38.8M$36.3M$18.5M$140.5M
Income statement
20252024202320222021
Revenue$1.46B$1.5B$1.27B$1.05B$637.4M
Cost of revenue$1.6B$0.00$0.00$0.00$668.1M
Gross profit-$-144.32M$1.5B$1.27B$1.05B-$-30.7M
Research and development expenses$0.00$0.00$0.00$0.00$0.00
Selling, general and administrative expenses$107.2M$113.9M$125.6M$162.4M$157.2M
Other expenses$18.8M$1.71B$1.31B$2.45B$46.6M
Operating expenses$126M$1.82B$1.43B$2.61B$157.2M
Cost and expenses$1.73B$1.82B$1.43B$2.61B$825.3M
Interest income$0.00$0.00$0.00$0.00$0.00
Interest expense$55M$22.2M$16M$11.4M$10.7M
Depreciation and amortization$84.2M$86.1M$86.7M$87.3M$8.72M
Ebitda-$-181.86M-$-197.76M-$-81.07M-$-1.46B-$-184.61M
Operating income-$-270.3M-$-320.66M-$-167.93M-$-1.56B-$-187.95M
Total other income/expenses, net-$-50.76M$6.61M-$-15.8M$1.22M-$-16.39M
Income before tax-$-321.06M-$-305.99M-$-183.73M-$-1.56B-$-204.34M
Income tax expense$2.02M$4.39M$2.69M$1.86M$0.00
Net income-$-147.95M-$-135.85M-$-57.77M-$-270.13M-$-156.48M
Weighted average shares outstanding$3.27M$2.9M$1.9M$830K$830K
Weighted average diluted shares outstanding$3.27M$2.94M$1.9M$830K$830K
Balance sheet
20252024202320222021
Cash and short-term investments$25M$38.8M$36.3M$18.5M$140.5M
Net receivables$92.5M$125.2M$121.5M$79.6M$51.3M
Inventory$0.00$0.00$0.00$0.00$0.00
Total current assets$133.1M$184.1M$166M$100.7M$199.9M
Property, plant and equipment, net$3.37M$5.73M$24M$20.5M$15.1M
Goodwill and intangible assets$492.4M$574.4M$666.7M$751.1M$2.15B
Long-term investments$0.00$0.00$0.00$3.5M$0.00
Total non-current assets$523.6M$599.3M$695M$776.1M$2.16B
Total assets$656.6M$783.4M$861M$876.7M$2.36B
Accounts payable$81.6M$64M$8.66M$176.4M$5.47M
Short-term debt$45M$65M$2.7M$1.6M$5.72M
Deferred revenue$0.00$0.00$0.00$0.00$0.00
Total current liabilities$545.3M$496.4M$299.4M$241.7M$198.8M
Long-term debt$239.9M$101.2M$121.9M$105.9M$86.3M
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$251.6M$137.5M$127.9M$112.4M$101.2M
Capital lease obligations$11.5M$11.3M$16.3M$11.5M$8.4M
Total liabilities$796.9M$633.9M$427.3M$354.1M$299.9M
Common stock$0.00$40K$30K$20K$20K
Retained earnings-$-651.14M-$-503.19M-$-367.34M-$-309.55M-$-39.42M
Accumulated other comprehensive income (loss)$0.00$0.00$0.00$0.00$0.00
Total equity-$-140.24M$149.5M$433.7M$522.7M$2.06B
Total investments$0.00$0.00$0.00$3.5M$0.00
Total debt$284.9M$166.2M$124.6M$107.5M$92M
Net debt$259.9M$127.4M$88.3M$89.1M-$-48.46M
Cash flow statement
20252024202320222021
Net income-$-319.04M-$-310.38M-$-186.43M-$-270.13M-$-156.48M
Depreciation and amortization$84.2M$86.1M$86.7M$87.3M$8.72M
Stock-based compensation$5.58M$5.75M$5.98M$0.00$0.00
Change in working capital$81.9M$88M$30.3M$34.8M$75.8M
Accounts receivable$26.4M-$-3.76M-$-41.99M-$-27.18M$450K
Inventory$0.00$0.00$0.00$0.00$0.00
Accounts payable$58.1M-$-8.1M$16M$46.4M$68.8M
Net cash provided by operating activities-$-91.24M-$-110.13M-$-76.03M-$-126.02M-$-66.47M
Investments in property, plant and equipment$80K$0.00-$-1.83M-$-2.23M-$-3.41M
Acquisitions, net$0.00$0.00$0.00-$-5.5M-$-52.87M
Net cash used for investing activities$130K$14.5M-$-1.83M-$-7.73M-$-56.07M
Common stock issued$0.00$0.00$86.6M$0.00$195.3M
Common stock repurchased$0.00$0.00$0.00$0.00$0.00
Dividends paid$0.00$0.00$0.00$0.00$0.00
Net cash used for financing activities$72.8M$98.8M$100.3M$11.4M$223.5M
Net change in cash-$-18.3M$3.17M$22.5M-$-122.38M$100.9M
Cash at end of period$25.8M$44.1M$40.9M$18.5M$140.8M
Operating cash flow-$-91.24M-$-110.13M-$-76.03M-$-126.02M-$-66.47M
Capital expenditure$80K$0.00-$-1.83M-$-2.23M-$-3.41M
Free cash flow-$-91.16M-$-110.13M-$-77.86M-$-128.25M-$-69.88M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About P3 Health Partners Inc.

        P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. The company operates clinics and wellness centers. P3 Health Partners Inc. was founded in 2020 and is based in Henderson, Nevada.

        CEO
        Aric Coffman
        Employees
        320
        Beta
        1.62

        Explore

        Frequently asked questions

        What is the intrinsic value of P3 Health Partners Inc. (PIII)?

        P3 Health Partners Inc. (PIII) is currently strongly undervalued based on the InvestorsCraft IC model — IC value is more than 50% above the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.

        Is PIII undervalued?

        PIII trades at a price of $1.69 (Nov 21, 2026): strongly undervalued — IC value is more than 50% above the price.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.